Friday, October 10, 2014

Researchers are currently accepting participants for a 6-month Natural History Study of Acute Porphyrias

Researchers are currently accepting participants for a 6-month Natural History Study of Acute Porphyrias

Alnylam Pharmaceuticals, Inc. is conducting a natural history study in collaboration with investigators from the American Porphyria Consortium to learn more about the symptoms and the treatment of patients with Acute Porphyrias. You may qualify to participate in this study if you have the diagnosis of acute intermittent porphyria, variegate porphyria or hereditary coproporhyria and have experienced at least 3 acute attacks in the last 12 months or have used Panhematin® or other medicines to prevent attacks. This study will not require you to change any current medication(s) nor require you to If you take part in this study, it will greatly help clinicians and researchers to understand more about porphyria. You will receive study-related medical care and monitoring.
This study will help to learn information about porphyria that could be important in the development of new therapies for patients with Acute Porhyrias.
Please contact us to get involved in the study: 713.266.9617 ornatalia@porphyriafoundation.org



"Remember....Research is the key to your cure!"

No comments:

Post a Comment

Health & Happiness!

Happiness & health Click to share on Facebook (Opens in new window) Click to share on Twitter (Opens in new window) Click to sh...